Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 15 Feb 2022 |
10 | Certificate | 28 Jul 2024 |
2 | Reply to Exam Report (MIS-R) | 31 Mar 2022 |
3 | Reply to Exam Report (MIS-R) | 05 Apr 2022 |
4 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 27 Sep 2022 |
5 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 17 Apr 2023 |
6 | Documents in support of Show cause Hearing (SCH) | 05 Sep 2023 |
7 | Documents in support of Show cause Hearing (SCH) | 25 Jan 2024 |
8 | Authorization Letter | 26 Feb 2024 |
9 | Journal Copy | 04 Jul 2024 |
1 | EXAMINATION REPORT | 13269589 | 30 Mar 2022 | |
2 | Hearing Notice (Show Cause) | 17126163 | 12 Jan 2024 | |
3 | Hearing Notice (Show Cause) | 17454704 | 20 Feb 2024 | |
4 | Tribunal Accepted Notice for : 5329340 | 17550379 | 6589893 | 27 Feb 2024 |
Trademark was applied on 15 February 2022 with IP India.
Proprietor of Dapzymir is Abbott Healthcare Private Limited.
Class(es) in which the trademark was applied to is 5.
Status of Dapzymir is Registered.
Application number alloted to the trademark is 5329340.
Zeusip Advocates Llp is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD